ekonominyheter

TranslateRSSMobil
Revlimid: Celgene Corporation's Gift That Keeps on Giving

Revlimid: Celgene Corporation's Gift That Keeps on Giving

Fool.com 23/10 14:06

Nearly nine years after FDA approval, Revlimid is still growing at 19%; other Celgene drugs aren't as prolific.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status